<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hsia K</submitter><funding>NCATS NIH HHS</funding><funding>Tufts University School of Medicine</funding><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><pagination>1613-1621</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10547232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Although gut fungi have been implicated in the immunopathogenesis of inflammatory bowel disease, the fungal microbiome has not been deeply explored across endohistologic activity and treatment exposure in ulcerative colitis.&lt;h4>Methods&lt;/h4>We analyzed data from the SPARC IBD (Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease) registry. We evaluated the fungal composition of fecal samples from 98 patients with ulcerative colitis across endoscopic activity (n = 43), endohistologic activity (n = 41), and biologic exposure (n = 82). Across all subgroups, we assessed fungal diversity and differential abundance of taxonomic groups.&lt;h4>Results&lt;/h4>We identified 500 unique fungal amplicon sequence variants across the cohort of 82 patients, dominated by</pubmed_abstract><journal>Inflammatory bowel diseases</journal><pubmed_title>Alterations in the Fungal Microbiome in Ulcerative Colitis.</pubmed_title><pmcid>PMC10547232</pmcid><funding_grant_id>KL2TR002545</funding_grant_id><funding_grant_id>R01 DK135937</funding_grant_id><funding_grant_id>KL2 TR002545</funding_grant_id><pubmed_authors>Zhao N</pubmed_authors><pubmed_authors>Algarrahi K</pubmed_authors><pubmed_authors>Michaud DS</pubmed_authors><pubmed_authors>Chung M</pubmed_authors><pubmed_authors>Montaser Kouhsari L</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Hsia K</pubmed_authors><pubmed_authors>Singh S</pubmed_authors><pubmed_authors>Fu M</pubmed_authors><pubmed_authors>Jangi S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alterations in the Fungal Microbiome in Ulcerative Colitis.</name><description>&lt;h4>Background&lt;/h4>Although gut fungi have been implicated in the immunopathogenesis of inflammatory bowel disease, the fungal microbiome has not been deeply explored across endohistologic activity and treatment exposure in ulcerative colitis.&lt;h4>Methods&lt;/h4>We analyzed data from the SPARC IBD (Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease) registry. We evaluated the fungal composition of fecal samples from 98 patients with ulcerative colitis across endoscopic activity (n = 43), endohistologic activity (n = 41), and biologic exposure (n = 82). Across all subgroups, we assessed fungal diversity and differential abundance of taxonomic groups.&lt;h4>Results&lt;/h4>We identified 500 unique fungal amplicon sequence variants across the cohort of 82 patients, dominated by</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-06-02T08:33:00.801Z</modification><creation>2026-04-16T03:11:35.481Z</creation></dates><accession>S-EPMC10547232</accession><cross_references><pubmed>37221272</pubmed><doi>10.1093/ibd/izad082</doi></cross_references></HashMap>